Seaport Therapeutics Statistics
NASDAQ: SPTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
18.05-0.27 (-1.47%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Seaport Therapeutics by the numbers
Seaport Therapeutics has a market capitalization of $966.2 million based on 53.53M shares outstanding. With trailing EPS of $-4.35, Seaport Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.1% below its 50-day average and 10.3% below its 200-day average.
Average daily trading volume is 259.83K shares, or about $4.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SPTX valuation vs. peer median
| Metric | SPTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $966.23M | $1.00B | -3% |
| Avg. volume | 259.83K | 1.02M | -74% |
Peer median across 8 companies: OMER, CYRX, ANRO, MLTX, SVRA, CTY, NKTR, JBIO.
Valuation
- Market cap
- $966.23M
- EPS (TTM)
- $-4.35
- Shares outstanding
- 53.53M
Price and trading
- Previous close
- 18.32
- Open
- 18.02
- Day range
- 17.41 – 18.83
- 52-week range
- 14.85 – 28.38
- Beta
- —
- Volume
- 284.27K
- Average volume
- 259.83K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 966.23M
- Forward Pe
- -7.54
- Eps
- -4.35
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 28.38
- Week52 Low
- 14.85
- Avg Volume
- 259.83K
- Shares Outstanding
- 53.53M
- Ma50
- 19.86
- Ma200
- 20.12
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -36.40%
- Pct From52w Low
- 21.55%